Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Muscarinic Antagonists administration & dosage"" wg kryterium: Temat


Wyświetlanie 1-5 z 5
Tytuł:
A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study
Autorzy:
Lehmann, Sverre
Ringbæk, Thomas
Løkke, Anders
Grote, Ludger
Hedner, Jan
Lindberg, Eva
Pokaż więcej
Temat:
Original Research
bronchodilator
sleep
hypoxia
quality of life
lung function
Respiratory Medicine and Allergy
Lungmedicin och allergi
OBSTRUCTIVE PULMONARY-DISEASE
SALMETEROL-FLUTICASONE
DOUBLE-BLIND
STANDARDIZATION
GLYCOPYRRONIUM
DESATURATION
THERAPY
Public Health, Environmental and Occupational Health
Health Policy
Pulmonary and Respiratory Medicine
General Medicine
FEV1/FVC ratio
Sleep disorder
medicine.disease
medicine
Indacaterol
medicine.drug
business.industry
business
Crossover study
Placebo
COPD
Asthma
Anesthesia
Somnolence
medicine.symptom
lcsh:Diseases of the respiratory system
lcsh:RC705-779
Adrenergic beta-2 Receptor Agonists/administration & dosage
Adult
Aged
Biomarkers/blood
Bronchodilator Agents/administration & dosage
Cross-Over Studies
Double-Blind Method
Female
Forced Expiratory Volume
Glycopyrrolate/administration & dosage
Health Status
Humans
Indans/administration & dosage
Lung/drug effects
Male
Middle Aged
Muscarinic Antagonists/administration & dosage
Norway
Oxygen/blood
Pulmonary Disease, Chronic Obstructive/blood
Quinolones/administration & dosage
Severity of Illness Index
Surveys and Questionnaires
Time Factors
Treatment Outcome
Vital Capacity
Journal Article
Multicenter Study
Randomized Controlled Trial
International Journal of Chronic Obstructive Pulmonary Disease
Źródło:
International Journal of Chronic Obstructive Pulmonary Disease
Lehmann, S, Ringbaek, T, Lokke, A, Grote, L, Hedner, J & Lindberg, E 2019, ' A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD : the DuoSleep study ', International Journal of Chronic Obstructive Pulmonary Disease, vol. 14, pp. 199-210 . https://doi.org/10.2147/COPD.S184127
The International Journal of Chronic Obstructive Pulmonary Disease
International Journal of COPD, Vol Volume 14, Pp 199-210 (2019)
Lehmann, S, Ringbæk, T, Løkke, A, Grote, L, Hedner, J & Lindberg, E 2019, ' A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD : the DuoSleep study ', International Journal of Chronic Obstructive Pulmonary Disease, vol. 14, pp. 199-210 . https://doi.org/10.2147/COPD.S184127
Opis pliku:
application/pdf; text/html
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c48d2846d648e8f2dd6491368b8f863
http://europepmc.org/articles/PMC6330967
Tytuł:
Differential anti-ischaemic effects of muscarinic receptor blockade in patients with obstructive coronary artery disease. Impaired vs normal left ventricular function
Autorzy:
W. J. Remme
M. van der Ent
D. J. Van Veldhuisen
G. L. Bartels
A. F. M. Van Den Heuvel
Pokaż więcej
Temat:
Cardiology and Cardiovascular Medicine
Coronary sinus
Internal medicine
medicine.medical_specialty
medicine
Atropine
medicine.drug
Anesthesia
Cardiology
Rate pressure product
business.industry
business
Muscarinic antagonist
Ventricular pressure
Coronary artery disease
medicine.disease
Heart catheterization
Heart failure
Atropine/*administration & dosage
Biological Markers/blood
Blood Flow Velocity/drug effects
Catecholamines/blood
Comparative Study
Coronary Angiography
Coronary Circulation/drug effects
Coronary Disease/complications/*drug therapy/physiopathology/radiography
Electrocardiography/drug effects
Female
Heart Catheterization
Humans
Infusions
Intravenous
Lactic Acid/blood
Male
Middle Aged
Muscarinic Antagonists/*administration & dosage
Myocardium/metabolism
Stroke Volume/drug effects
Ventricular Dysfunction
Left/blood/*complications/drug therapy/physiopathology
Ventricular Function
Left/drug effects/*physiology
Ventricular Pressure/drug effects
endothelial functionischaemia
coronary disease
endothelial function ischaemia
muscarinic antagonists
MYOCARDIAL-ISCHEMIA
HEART-FAILURE
BLOOD-FLOW
ACETYLCHOLINE
VASOCONSTRICTION
ENDOTHELIUM
DYSFUNCTION
ACTIVATION
Infusions, Intravenous
Ventricular Dysfunction, Left/blood/*complications/drug therapy/physiopathology
Ventricular Function, Left/drug effects/*physiology
Źródło:
European Heart Journal, 20(23), 1717-1723. Oxford University Press
European Heart Journal, 20(23), 1717-1723
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a988b9783c98c2505653ef41f3f141b3
http://academic.oup.com/eurheartj/article-pdf/20/23/1717/17882539/1717.pdf
Tytuł:
Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD—a randomised controlled study
Autorzy:
Salomon, Joerg
Stolz, Daiana
Domenighetti, Guido
Frey, Jean-Georges
Turk, Alexander J.
Azzola, Andrea
Sigrist, Thomas
Fitting, Jean-William
Schmidt, Ulrich
Geiser, Thomas
Wild, Corinne
Kostikas, Konstantinos
Clemens, Andreas
Brutsche, Martin
Pokaż więcej
Temat:
Pulmonary and Respiratory Medicine
610 Medicine & health
Vital capacity
Indacaterol
medicine.drug
medicine
Anesthesia
Bronchodilator
medicine.drug_class
FEV1/FVC ratio
Spirometry
medicine.diagnostic_test
COPD
medicine.disease
Lung volumes
Airway resistance
business.industry
business
Adrenergic beta-2 Receptor Agonists/administration & dosage
Adult
Aged
Aged, 80 and over
Cross-Over Studies
Diagnosis, Computer-Assisted/methods
Double-Blind Method
Drug Combinations
Female
Glycopyrrolate/administration & dosage
Humans
Indans/administration & dosage
Male
Middle Aged
Muscarinic Antagonists/administration & dosage
Placebo Effect
Plethysmography, Whole Body/methods
Pulmonary Disease, Chronic Obstructive/diagnosis
Pulmonary Disease, Chronic Obstructive/drug therapy
Pulmonary Disease, Chronic Obstructive/physiopathology
Quinolones/administration & dosage
Reproducibility of Results
Respiratory Function Tests/methods
Sensitivity and Specificity
Spirometry/methods
Switzerland
Treatment Outcome
Body plethysmography
Glycopyrronium
Research
respiratory tract diseases
biochemical phenomena, metabolism, and nutrition
Źródło:
Salomon, Joerg; Stolz, Daiana; Domenighetti, Guido; Frey, Jean-Georges; Turk, Alexander J; Azzola, Andrea; Sigrist, Thomas; Fitting, Jean-William; Schmidt, Ulrich; Geiser, Thomas; Wild, Corinne; Kostikas, Konstantinos; Clemens, Andreas; Brutsche, Martin (2017). Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study. Respiratory research, 18(1), p. 13. BioMed Central 10.1186/s12931-016-0498-1 <http://dx.doi.org/10.1186/s12931-016-0498-1>
Respiratory research, vol. 18, no. 1, pp. 13
Respiratory Research
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6922429012900f149e67ba56981220dc
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

    Prześlij opinię

    Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

    Formularz